OpenAlex
PricingAboutJobs
Log inGet started
Work

HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches

HTML

Year: 2018
Type: article
Source: European Journal of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2018.08.081
Authors: Nilanjan Adhikari, Sk. Abdul Amin, Prakruti Trivedi, Tarun Jha, Balaram Ghosh
Institutions: Jadavpur University, Birla Institute of Technology and Science - Hyderabad Campus
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: HDAC3, histone deacetylase inhibitors, benzamide derivatives, zinc-binding groups, QSAR, structure-activity relationship, anticancer drug design
SDG: Good health and well-being

Open Access status: closed

Funder: University Grants Commission
OpenAlex ID: W2888790527
FWCI: 2.091
Cites: 144
Cited by: 87
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security